Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Millions.
The item "Current-Deferred-Revenue" stands at 132.00 Million Euros as of 06/30/2024, the lowest value at least since 03/31/2021, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -64.99 percent compared to the value the year prior.
The 1 year change in percent is -64.99.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Current Deferred Revenue | 905,699,262,464.00 |
![]() | Johnson & Johnson - Current Deferred Revenue | 486,508,953,600.00 |
![]() | AbbVie Inc - Current Deferred Revenue | 399,570,305,024.00 |
![]() | Roche Holding AG - Current Deferred Revenue | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Current Deferred Revenue | 280,205,508,085.11 |